Aerie Pharmaceuticals

Aerie’s mission is to discover and develop novel, first-in-class medications that help patients with glaucoma preserve their sight.  Read more

Vicente Anido's photo - Chairman & CEO of Aerie Pharmaceuticals

Chairman & CEO

Vicente Anido

CEO Approval Rating

87/100

Founded:

2005

Status:

PublicIndependent CompanyNASDAQAERI

AERIE PHARMACEUTICALS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Bausch & Lomb, Inc. is one of Aerie Pharmaceuticals's top rivals. Bausch & Lomb, Inc.'s headquarters is in Bridgewater, New Jersey, and was founded in 1853. Bausch & Lomb, Inc. operates in the Health Care Equipment industry. Bausch & Lomb, Inc. generates 5,713% of Aerie Pharmaceuticals's revenue.

Alcon has been one of Aerie Pharmaceuticals's top competitors. Alcon was founded in 1945 in Fort Worth, Texas. Alcon is in the Health Care Services industry. Alcon generates $6.7B more revenue than Aerie Pharmaceuticals.

Allergan is one of Aerie Pharmaceuticals's top competitors. Allergan was founded in Coolock, County Dublin} in 1948. Allergan operates in the Health Care Supplies industry. Compared to Aerie Pharmaceuticals, Allergan generates $15.9B more revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Abbott Medical Optics a competitor of Aerie Pharmaceuticals?

Aerie Pharmaceuticals Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$85.8M

Aerie Pharmaceuticals's revenue is the ranked 15th among it's top 10 competitors. The top 10 competitors average 14.6B. Over the last four quarters, Aerie Pharmaceuticals's revenue has grown by 27.4%. Specifically, in Q1 2021's revenue was $23M; in Q4 2020, it was $24.7M; in Q3 2020, it was $20.1M; in Q2 2020, Aerie Pharmaceuticals's revenue was $18M.

Aerie Pharmaceuticals Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Avizorex Pharma, S.L.

Nov 2019

Source »
$10M
AVX Pharma is a clinical-stage biopharmaceutical company that develops and commercializes novel therapies for dry eye syndrome.

These are all the companies that Aerie Pharmaceuticals has acquired. Aerie Pharmaceuticals' latest acquisition was Avizorex Pharma, S.L. in Nov 2019. AVX Pharma is a clinical-stage biopharmaceutical company that develops and commercializes novel therapies for dry eye syndrome.

Aerie Pharmaceuticals Funding History

Since Aerie Pharmaceuticals was founded in 2005, it has participated in 7 rounds of funding. In total Aerie Pharmaceuticals has raised $580.0M. Aerie Pharmaceuticals' last funding round was on Sep 2019 for a total of $316.5M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Convertible Note
Sep 2019
$316.5M
-
Debt
Sep 2014
$125M
-
IPO
Oct 2013
$67.2M

Debt
Dec 2012
$15M
Series B
Mar 2011
$30M

Since Aerie Pharmaceuticals was founded in 2005, it has participated in 7 rounds of funding. In total Aerie Pharmaceuticals has raised $580.0M. Aerie Pharmaceuticals' last funding round was on Sep 2019 for a total of $316.5M

Aerie Pharmaceuticals Investments

No recent investments found related to Aerie Pharmaceuticals

These are all the companies that Aerie Pharmaceuticals has invested in. Aerie Pharmaceuticals' latest investment was Avizorex Pharma, S.L. in Nov 2019. AVX Pharma is a clinical-stage biopharmaceutical company that develops and commercializes novel therapies for dry eye syndrome.

Aerie Pharmaceuticals News

April 28, 2021MarketScreener

Announces Presentations at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

(marketscreener.com) Aerie Pharmaceuticals, Inc. , an ophthalmic pharmaceutical company focused on th... See more »
April 19, 2021MarketScreener

Receives Marketing Authorisation of Roclanda 50 micrograms/ml + 200 micrograms/ml Eye Drops, Solution (latanoprost + netarsudil) in Great Britain

(marketscreener.com) Aerie Pharmaceuticals, Inc. , an ophthalmic pharmaceutical company focused on th... See more »
April 14, 2021MarketScreener

Corporate Presentation - April

(marketscreener.com) Company Overview Investor Presentation April 2021 Important Information The info... See more »
April 7, 2021MarketScreener

to Participate in the 20th Annual Needham Virtual Healthcare Conference

(marketscreener.com) Aerie Pharmaceuticals, Inc. , an ophthalmic pharmaceutical company focused on th... See more »
March 1, 2021Benzinga

Looking Into Aerie Pharmaceuticals's Return On Capital Employed

During Q4, Aerie Pharmaceuticals's (NASDAQ:AERI) reported sales totaled $24.68 million. Despite a 5.9... See more »
February 22, 2021MarketScreener

to Participate in Upcoming Virtual Investor Conferences

(marketscreener.com) Aerie Pharmaceuticals, Inc. , an ophthalmic pharmaceutical company focused on th... See more »
February 18, 2021MarketScreener

to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on Thursday, February 25, 2021

(marketscreener.com) Aerie Pharmaceuticals, Inc. , an ophthalmic pharmaceutical company focused on th... See more »

Aerie Pharmaceuticals Press Releases

March 30, 2021Business Wire

Aerie Pharmaceuticals Announces Publication of Peer-Reviewed Paper Evaluating the Treatment Effect of Netarsudil on Outflow Function in Steroid-Induced Glaucoma

DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutic... See more »
March 11, 2021Business Wire

Aerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit Dry Eye Innovation Showcase

DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutic... See more »
March 11, 2021Business Wire

Aerie Pharmaceuticals to Participate in the Oppenheimer 31st Annual Virtual Healthcare Conference

DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutic... See more »
November 5, 2020Business Wire

Aerie Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Update

DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutica... See more »
May 6, 2020Business Wire

Aerie Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update

DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutica... See more »
September 6, 2019PRcom

Aerie Pharmaceuticals Speaker Interview Released for SMi's Ophthalmic Drugs Conference 2019

Ophthalmic Drugs conference speaker interview. [PR.com]... See more »
May 7, 2019StreetInsider

Aerie Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the disco... See more »

Social Media

Aerie Pharmaceuticals Headquarters

550 Hills Drive Suite 15

Bedminster, New Jersey07921

908-470-4320

Driving Directions »

Trending Companies

Aerie Pharmaceuticals Summary

ABOUT

Overview

Aerie’s mission is to discover and develop novel, first-in-class medications that help patients with glaucoma preserve their sight.  Aerie Pharmaceuticals was founded in 2005. Aerie Pharmaceuticals' headquarters is located in Bedminster, New Jersey, U...

CEO

Aerie Pharmaceuticals's Chairman & CEO, Vicente Anido, currently has an approval rating of 87%. Aerie Pharmaceuticals's primary competitors are Bausch & Lomb, Inc., Alcon & Allergan.

Frequently Asked Questions about Aerie Pharmaceuticals

  1. When was Aerie Pharmaceuticals founded?

    Aerie Pharmaceuticals was founded in 2005
  2. Who is Aerie Pharmaceuticals's CEO?

    Aerie Pharmaceuticals's CEO is Vicente Anido
  3. How much revenue does Aerie Pharmaceuticals generate?

    Aerie Pharmaceuticals generates $85.8M in revenue
  4. How much funding does Aerie Pharmaceuticals have?

    Aerie Pharmaceuticals has historically raised $580M in funding
  1. Where is Aerie Pharmaceuticals's headquarters?

    Aerie Pharmaceuticals's headquarters is in Bedminster New Jersey, USA
  2. How many employees does Aerie Pharmaceuticals have?

    Aerie Pharmaceuticals has 353 employees
  3. Who are Aerie Pharmaceuticals's competitors?

    Aerie Pharmaceuticals's top competitors are Bausch & Lomb, Inc., Alcon, Allergan